-
公开(公告)号:US20210301005A1
公开(公告)日:2021-09-30
申请号:US17205663
申请日:2021-03-18
Applicant: Genentech, Inc.
Inventor: Wei-Ching LIANG , Joseph R. ARRON , Daryle DEPIANTO , Wendy Green HALPERN , WeiYu LIN , Patrick J. LUPARDUS , Thirumalai Rajan RAMALINGAM , Dhaya SESHASAYEE , Tianhe SUN , Tulika TYAGI , Jia WU , Yan WU , Jian Ping YIN
Abstract: The invention provides isoform-selective anti-TGFβ antibodies and methods of using the same. In particular, isoform-selective anti-TGFβ2, anti-TGFβ3, and anti-TGFβ2/3 monoclonal antibodies are provided, e.g., for the treatment of fibrosis and other TGFβ-related disorders.
-
公开(公告)号:US20240327522A1
公开(公告)日:2024-10-03
申请号:US18621505
申请日:2024-03-29
Applicant: Genentech, Inc.
Inventor: WeiYu LIN , Kelly Michele LOYET , Matthieu MASUREEL , Minh THAI , Shannon Jennifer TURLEY , Tulika TYAGI , Yan WU , Jianhuan ZHANG , Alessandra CASTIGLIONI , Cecilia Pui Chi CHIU
CPC classification number: C07K16/2842 , A61P35/00 , C07K16/2818 , A61K2039/507 , C07K2317/24 , C07K2317/52 , C07K2317/565 , C07K2317/76 , C07K2317/92
Abstract: Provided herein are anti-αvβ8 antibodies or antigen-binding portions thereof and methods of making and using the same. Further provided are methods of treating cancer with an anti-αvβ8 and a PD-1 axis antagonist.
-